EDANS

CAS No. 50402-56-7

EDANS( EDANS acid [5-((2-Aminoethyl)amino)napht | 1,5-EDANS )

Catalog No. M24462 CAS No. 50402-56-7

EDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
50MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EDANS
  • Note
    Research use only, not for human use.
  • Brief Description
    EDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).
  • Description
    EDANS is a novel and quenched fluorogenic substrate for assaying retroviral protease by resonance energy transfer (RET).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    EDANS acid [5-((2-Aminoethyl)amino)napht | 1,5-EDANS
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    50402-56-7
  • Formula Weight
    266.32
  • Molecular Formula
    C12H14N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:13.89 mg/mL (52.16 mM; Need ultrasonic)
  • SMILES
    NCCNc1c(cccc2S(O)(=O)=O)c2ccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.E D Matayoshi, et al. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 1990 Feb 23;247(4945):954-8.
molnova catalog
related products
  • TASIN-1 Hydrochlorid...

    TASIN-1 Hydrochloride is a selective inhibitor of truncated APC that acts by selectively killing colorectal cancer cells that express truncated APC by reducing cellular cholesterol levels and inducing apoptotic cell death through the ER stress/ROS/JNK signaling in colon cancer cells.

  • AZ-Dyrk1B-33

    AZ-Dyrk1B-33 is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM.

  • RC-3095

    RC-3095, a selective GRPR antagonist, has been shown to have anti-inflammatory properties in different models of inflammation.